Tunnicliff G, Welborn K L, Ngo T T
Gen Pharmacol. 1985;16(1):25-9. doi: 10.1016/0306-3623(85)90265-4.
In an attempt to identify potential anticonvulsant compounds, 18 structural analogues of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) were tested for their ability to inhibit GABA receptor binding, sodium-dependent GABA binding and GABA aminotransferase activity in synaptic membranes from mouse brain. Nine inhibitors of receptor binding were found. The most potent was N-(thiocarbamoyl)glycine (Ki = 18 microM). However, this compound had no real effect on Na+ -dependent GABA binding nor on the activity of GABA aminotransferase. In addition, it was unable to enhance the binding of [3H]flunitrazepam as GABA agonists usually do. This could indicate that this inhibitor is, rather, a GABA receptor antagonist. Even though no particularly potent inhibitors of any of the GABA recognition sites were found, this technique nevertheless demonstrates how simple in vitro assays can be used to find drugs exhibiting potential GABA-mimetic activity.
为了鉴定潜在的抗惊厥化合物,对抑制性神经递质γ-氨基丁酸(GABA)的18种结构类似物进行了测试,以检测它们抑制小鼠脑突触膜中GABA受体结合、钠依赖性GABA结合及GABA转氨酶活性的能力。发现了9种受体结合抑制剂。其中最有效的是N-(硫代氨基甲酰基)甘氨酸(Ki = 18微摩尔)。然而,该化合物对钠依赖性GABA结合及GABA转氨酶活性并无实际影响。此外,它也不能像GABA激动剂通常那样增强[3H]氟硝西泮的结合。这可能表明该抑制剂更像是一种GABA受体拮抗剂。尽管未发现对任何GABA识别位点有特别强效的抑制剂,但该技术仍证明了简单的体外试验可如何用于寻找具有潜在GABA模拟活性的药物。